Literatur

Literatur

1. Centers for Disease Control: Revision of the CDC surveillance ease definition for acquired immunodeliciency syndrome. J. Am. Med. Assoe. 258, 1143 -54 (1987).

2. Institute of Medicine: Confronting AIDS. (National Academy Press, Washington, DC) (1986).

3. Institute of Medicine: Confronting AIDS-Update 1988. (National Acaderny. Press, Washington, DC) (1988).

4. Centers for Disease Control: HIV/AIDS Surveillance, Yearend edition. (January) U. S. Department of Health and Human Services, Atlanta, GA (1992).

5. Duesberg, P. H.: AIDS epiderniology: inconsisteneies with human immunodeficienc3r virus and with infectious disease. Proc. Natl. Acad. Sei. USA 88, 1575 -79 (1991).

6. Duesberg, R H.: Human iminunodeficieney virus and acquired immunodeficiency syndrome: Correlation but not causation. Proc. Natl. Acad. Sei. USA 86, 755 -764 (1989).

7. Stutman, 0.: Immunodepression and malignancy. Adv., Cancer Res. 22, 261-422 (1975),

8. World Health Organization: WHO Report No 30: AIDS surveillance in Europe. (June 30) World Health Organization, Geneva (1991).

9. National Commission on AIDS: The Twin Epidemics of Substance Use and HIV. (July) National Commission on AIDS, Washington, D. C. (1991).

Root-Bernstein, R.: Do we know the eause(s) of AIDS?

Per spect. Biol. Med~ 33, 480 -500 (1990). ,

Beral, V, Peterrnan, T. A., Berkelman, R.L., Jaffe, H.W.: Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335, 123,-128 (1990).

12. Ettinger, N. A., Albin, R, J.: A review of the respiratory effects of smoking cocaine. Am. J. Med. 87, 664 -668 (1989).

13. Pluda, J. M., Yarchoan, R., Jaffe, E. S. et al.: Development of nen-Hodgkin lymphoma in a cohort of patients with severe human imrnunodefieieney virus (HIV) infeetion on long-term antiretroviral therapy. Ann. Intern. Med. 113, ,276-282 (1990).

14. Richman, D. D., Fischl, M. A., Grieco, M. H. et al.: The A.ZT Collaborative Working Group: The toxicity of azidothymidine (AZT) in the treatment of patients W-Ith AIDS and AIDS-related complex. N. Engl. J. Med. 317, 192-197 (1987).

15. Smothers, K~: Pharmacology and toxicology of AIDS therapies. The AIDS Reader 1, 29 -35 (1991).

16. Blattner, W., Gallo, R. C~, Teinin, H. M.: HIV causes AIDS. Science 241, 514 -515,(1988)'

17. Baltimore, D., Feinberg, M. B.: Quantification of human irnmunodefielency virus in the blood. N. Engl. J. Medi 321, 1673-75 (1990).

18. Gallo, R. C.: Virus Hunting -AIDS, Cancer, & the Human Retrovirus: A Story of Scientific Discovery~ (Basie Books, New York) (1991).

19. Verrnund, S.: Changing estimates of HIV-1 seroprevalence in the United States. J. NIH Res. 3, 77 -81 (1991).

20. Bregman, D. J., Langmuir, A. D.: Farr's law applied to AIDS

projertions, J. Am. Med. Assoc. 263, 50 -57 (1990).

21. Freeman, B. A.: Burrows Textbook of Mierobiology. (W. B. Saunders Co., Philadelphia) (1979).

22. Quinn, T.C., Mann, J.M., Curran, J.W., Piot, P.: AIDS in Africa: an epidemiologieal paradigm. Science 234, 955 -963 (1986).

23. Uwrence, D. N., Jason, J. M., Holman, R. C., Murphy, J. J.: HIV transmission from hernophiliae men to their hetetosexual partners, in: Heterosexual Transinission of AIDS, eds.: Alexander, N. J., Gabelnick, H. L., Spieler, J. M. (WileyLiss, New York), 35 -53 (1990).

24. Van Voorhis, B. J., Martinez, A., Mayer, K., Anderson, D. J.: Detection of human immunodeficieney virus type 1 in semen frorn seropositive men using eulture and polymerase chain reaction desoxyribbnucieic acid ~mplilication techniques. Fertility and Sterility 55, 588 -594 (1991).

25. Duesberg, P. H.: Retroviruses as careinogens and pathogens: expeetations and reality. Cancer Res. 47, 1199-1220 (1987).

26. Evans, A. S.: Viral Iniections of Humans, Epidemiology 50. and Control. (Plenum Publishing Corporation, New York) (1989).

27. Mims, C., White, D. 0.: Viral Pathogenesis and Im- 51. munology. (Blackweel Seientific Publications, Oxford) (1984).

28, Clark, S. J., Saag, M. S., Decker, W. D. et al.: High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-infection. N. Engl. J. Med. 324, 954 -960 (1991).

29. Daar, E. S., Moudgil, T., Meyer, R. D., Ho, D. D.: Transient high levels of viremia in patients with primary human im munodeficieney virus type 1 infeetion. N. Engl. J. Med. 324, 961-964 (1991).

30. Aral, S. 0., Holmes, K. K.: Sexually transmitted diseases in the AIDS era. Sei. Am. 264, 62 -69 (1991).

31. Judson, F. N., Penley~ K. A., Robinson, M. E., Smith, J. K.: Comparative prevalence rates of sexually transmitted diseases in heterosexual and homosexual men. Am. J. Epidemiol. 112, 836 -,843 (1980).

32. Braun, M. M., Truman, B. I., Maguire, B. et al.: Iiiereasing incidence of tuberculosis in a prison inmate population, assoeiated with HIV-infection. J. Am. Med. Assoc. 261, 393-397 (1989).

33. Stoneburner, R. L., Des Jarlais, D. C" Benezra, D. et al.: A larger speetrum of severe~ HIV-I-related disease in in tiavenous drug users in New York City. Seience 242, 916 -919 (1988),

34. Gill, P. S., Rarick, M., Byrnes, R. K. et al.: Azidothyn-Iidine associated with bone marrow failure in the acquired im munodeficiency syndrome (AIDS). Ann. Int. Med. 107, 502-505 (1987).

35. Yarchoan, R., Broder, S.: Development of antiretroviral therapy for the acquired immunodefleiency syndrome and related disorders. N. Engl. J. Med. 316, 557 -564 (1987).

36. Albonico, H.: Lichtblicke zum zweiten Jahrzehnt in der AIDSmForschung. Schweizerische Ärztezeitung 72, 379 -380 (1991).

37. Centers for Disease Control: Epidemiologic aspeets of the current outbreak of Kaposi's sarcoma and opportunistic in feetions. N. Engl. J. Med. 306, 248 -252 (1982).

38. Duesberg, P H.: AIDS: non-infeetious deficieneies acquired by drug consumption and other risk factors. Res. Immunol. 141, 5-11 (1990).

39. Haverkos, H. W.: Epidemiologie studies -Kaposi's sar-coma versus opportunistie infeetions among homosexual men with AIDS, in: Health Hatards of Nitrite Inhalants, eds.: Haverkos, H.W., Dougherty, J. A. (NIDA Res. Monogr. 83, National Institute on Drug Abuse, Washington, DC), 96 -105 (1988).

40. Holub, W. R.: AIDS: a new disease? Am. Clin. Prod. Rev. 7, 28-37 (1988)., 41. Lauritsen, J., Wilson, H.:,Death Rush, Poppers and AIDS. (Pagan Press, New York) (1986).

42. Marmor, M., Friedman-Kien, A. E., Laubenstein, L. et al.: Risk factors for Kaposi's sarcoma in homosexual men. Lancet i, 1083 -87 (1982).

43. Pa adopulos-Eleopulos, E.: Reappraisal of AIDS -Is the , p oxidation induced by the risk factors the primary eause? Med. Hypotheses 25, 151-162 (1988).

44. Rappoport, J.: AIDS INC. (Human Energy Press, San Bruno, CA) (1988).

45. Bureau of Justiee Statisties: Speeial Report -Drug Law Violators, 1980-1986. U.S. Department of Justiee, Washington, DC, (1988). Flanagan, T. J., Maguire, K.: Sourcebook of Criminal Justiee Statistics (1989) -Bureau of Justiee Statisties NCJ-124224. (U. S., Department of Justiee, U. S. Government Printing Office, Washington, DC) (1989).

47. Haverkos, H. W.: Kaposi's sarcoma and nitrite inhalants, in: Psychological, Neuropsychiatrie and Substance Abuse Aspeets of AIDS, eds.: Bridge, T. P., Heather, H., Johnson, M. (Raven Press, New York), 165 -172 (1988).

48. Lerner, W. D.: Cocaine abuse and acquired immunodeficieney syndrome: tale of two epidemies. Am. J. Med. 87, 661-663 (1989).

49. National Institute on Drug Abuse: 'lYends in Drug Abuse Related Hospital Emergency Room Episodes and Medical Examiner Cases for Selected Drugs: DAWN 1976 -1985. (Na tional Institute on Drug Abuse, Bethesda, MD) (1987)

50. Office of National Drug Control Policy: The National Narcoties Intelligence Consumers Conimittee Reports. (Exeeutive Office of the President, Washington, DC) (1988).

51. Shannon, E., Booth, C., Fowler, D., McBride, M.: A loosing battle. Time 136 (24), p. 44 -48, December 3 (1990).

52. Bureau of Justiee Statistics: Catalogue of federal publications on illegal drug and alcohol abuse. U.S. Dept. of Justice, Washington IjC (1991).

53. Anderson, W.: Drug Smuggling. (U. S. General Accounting , Office, Washington, DC) (1987).

54. Newell, G. R., Spitz, M. R., Wilson, M, B.: Nitrite inhalants: historical perspective, in: Health Hazards of Nitrite Inhalants, eds.: Haverkos, H. W., Dougherty, J. A. (NIDA Resi Monogr. 83, National Institute on Drug Abuse, Washington, DC), 1-14 (1988).

55. Wood, R. W.: The acute toxieity of butyl nitrites, in: Health Hazards of Nitrite Inhalants, eds.: Haverkos, H. W., Dougherty, J. A. (NIDA Res. Monogr. 83, National Institute on Drug Abuse, Washington, DC), 28 -38 (1988).

56. Schwartz, R. H.: Delibe -rate inhalation of isobutyl nitrite during adoleseence: a deseriptive study, in: Health Hazards of Nitrite Inhalants, eds.: Haverkos, H. W., Dougherty, J. A. (NIDA Res. Monogr. 83, National Institute on Drug Abuse, Washington, DC), 81 -85 (1988).

57. Kolata, G.: Marrow suppression hampers AZT use in AIDS vietims. Science 235, 1463 (1987).

58. Buehler, J.W., Devine, 0.J., Berkelman, R.L., Chevarley, F. M.: Impaet of the human immunodefieieney virus ,epidemie on mortality trends in young men, United States. Am. J. Pub. Health 80, 1080 -86 (1990).

59. National Center for Health Statisties: Monthly Vital Statistics Report (Department of Health and Human Ser-, viees -Public Health Service Publication No. (PMSi 89 -1120, Hyattsville, MD) (1989).

60. Selwyn, P A., Hartel, D., Wasserman, W., Drucker, E.: Inipact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance prograrn. Am. J. Public Health 79, 1358-62 (1989).

61. Toufexis, A.: Innocent victims. Time 137, p. 56-60, May 13 (1991).

62. Ginzburg, H.M.: Acquired immune deficieney syndrorne (AIDS) and drug abuse, in: AIDS and IV Drug Abusers Current Perspectives, eds.: Galea, R. P., Lewis, B. F., Baker, L. (National Health Publishing, Owings Mills, MD), 61-73 (1988).

63. Darke, S., Hall, W., Heather, N. et al.: The reliability and validity of a scale to measure HIV risk-taking behaviour ainong intravenous drug users. AIDS 5, 181-185 (1991).

64. Darrow, W. W., Echenberg, D. F., Jaffe, H. W. et al.: Risk factors for human immunodeficiency virus (HIV) infeetions in homosexual men. Am. J, Publ. Health 77, 479 -483 (1987).

65. Turner, C. F., Miller, H. G., Moses, L. E.: AIDS, Sexual Behavior and Intravenous Drug Use. (National Academy Press, Washington, DC) (1989),

66. Ostrow, D. G., Van Raden, M. J., Fox, R. et al.: Recreational drug use and sexual behavior change in a cohort of hornosexual men. AIDS 4, 759 -765 (1990).

67. Adams, J.: AIDS: the HIV Myth. (St. Martin's Press, New York) (1989).

68. Blattner, W. A., Biggar, g. J., Weiss, S. H. et al.: Epidemiology of human lymphotropic retroviruses: an overview. Cancer Res. 45 supplement, 4598s -4601s (1985).

69. Raymond, C.A.: Combating ä deadly combination: intravenous drug abuse, acquired immunodefieiency syiidrome. N. Engl. J. Med. 259, 329, 332 (1988).

70. Lesbian & gay substance abuse planning group: Gay men, lesbians and their aleohol and other drug use: a review of the literature. (September) San Francisco Department of Public Health, San Francisco, CA (1991).

71. Shilts, R.: And the Band Played On. (St. Martin's Press,

New York) (1985).

72. Weiss, S. H.: Links between cocaine and retroviral infection. J. Am. Med. Assoe. 261, 607 -609 (1989).

73. Lemp, G. F., Payne, S. F., Rütherford, G. W. et al.: Projections of,AIDS morbidity and mortality in San Francisco. J. Am. Med. Assoe. 263, 1497 -1501 (1990).

74. Moss, A. R., Osmond, D., Baechetti, R: The eause of AIDS.

Seience 242, 997 (1988).

75. Mirvish, S. S., Haverkos, H. W.: Butylnitrite in the induetion of Kaposi's sarcoma in AIDS. N. Engl. j. Med. 317, 1603 (1987).

76. Lesbian & gay substance abuse planning group: San Franeisco Lesbian, Gay and Bisexual Substance Abuse Needs Assessment. (August) San Francisco, Departmeht of Publie Health, San Francisco, CA (1991).

77. Fischl, M. A., Richman, D. D., Grieco, M. H. et al.: The effieacy of azidot4ymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N. Engl. J. Med. 317, 185-191 (1987).

78. Editorial: Zidovudine for symptomless HIV infeetion. Lancet 335, 821 -822 (1990).

79. Volberding, A A. et al., the AIDS Clinical Trial Group: Zidovudine in asymptomatie human immunodeficiency virus infection: A cQ ntrolled trial in persons with fewer than 500 CD4-positive cells per cubie millimeter. N. Engl. J. Med. 322, 941-949 (1990).

80. Multicenter AIDS Cohort Study: Message From Jan. LAMS Newsletter, p. 1 -2, March (199 1).

81. Centers for Disease Control: Update: acquired immunodeficiency syndrome -United States. Morb. & Mört. Weekly Rpts 34, 245 -248 (1985).

82. Gottlieb, M. S., Schanker, H. M., Fan, P T. et al.: Pneumoeystis pneumonia -Los Angeles. Morb. & Mort. Weekly Rpts. 30, 250-252 (1981).

83. lange, W. R., Dax, E. M., Haertzen, C. A. et al.: Nitrite inhalants: contemporary patterns of abuse, in: Health Hazards of Nitrite Inhalants, eds.: Haverkos, H. W., Dougherty, J. A. (NIDA Res. Monogr. 83, National Institute on Drug Abuse, Washington, DC), 86 -94 (i~88).

84. Weber, R., Ledergerber, W., Opravil, M. et al.: Progression of HIV infection in misusers of injeeted drugs who stop injeeting or follow a programme of maintenance treatment with methadone. Br. Med. J. 301, 1361 -65 (1990).

85. Des Jarlais, D., Friedman, S., Marmor, M. et al.: Developrnent of AIDS, HIV seroconversiön, and potential cofactors for T4 cell loss in a cohort of intravenous drug users. AIDS 1, 105-111 (1987).

86, Dournon, E., Rozenbaum, W., Michon, C. et al.: Efferts of zidovudine in 365 conseeutive patients with AIDS or AIDSrelated c omplex. Lancet ii, 1297 -1302 (1988).

87. Swanson, C. E., Cooper, D. A., the Australian Zidovudine Study Group: Factors influencing outcome of treatment with zidovudine of patients with AIDS in Australia. AIDS 4, 749-757 (1990).

88. Reinvang_ I., Froland, S. S., Karlsen, N. R., Lundervold, A.J.: Only temporary improvement in impaired neuropsychologieal funetion in AIDS patients treated with zidovudine. AIDS 5, 228 -229 (1991).

89. Peters, B. S., Beck, E. J., Coleman, D. G. et al.: Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS. Br. Med. J, 302, 203-207 (1991),

90. Scolaro, M., Durham, R., Pieczenik, G.: Potential molecular competitor for HIV. Lancet 33 7, 731 -732 (1991).

91. Till, M., MacDonnell, K. B:: Myopathy with human immunodefieiency virus type 1 (HIV-1) infeetion: HIV-1 or zidovudine? Ann. Int. Med. 113, 492 -494 (1990).

92. Selwyn, P. A., Feingold, A. R., Hartel, D. et al.: Inereased risk of baeterial pneumonia in'I4IV-infeeted intravenous drug users without AIDS. AIDS 2, 267 -272 (1988). ~

93. Dohohoe, R. M., Falek, A.: Psychological, neuropsychiatric and substance abuse aspects of AIDS, in: eds.: Bridge, T. P. et al. (Raven Press, New York), 145 -158 (1988).

94. Savona, S., Nardi, M.A., Lenette, E.T., KarpatkW, S.: Thrombocytopenie purpura in nareotics addiets. Ann. Int. Med. 102, 737 -741 (1985).

95. Mientjes, G. H., Miedema, F., van Ameij den, E. J. et al.: Frequent injeeting impairs lymphoeyte reactivity in HIVpositive and HIV-negative drug users. AIDS 5, 35 -41 (1991).

96. Des Jarlais, D. C., Friedman, S. R., Hopkins, W.: Ri�k reduetion of the acquired immunedefieieney syndrome among intravenous drug users, in: AIDS and IV Drug Abusers, Current Perspectives, eds.: Galea, R. P., Lewis, B. F., Baker, L. (National Health Publishing, Owings Mills, MD), 97-109 (1988).

97. Espinoza, R, Bouchard, 1., Buffet, C. et al.: High prevalence. of infection by hepatitis B virus and HIV in incarcerated FreticWdrug addiets. Gastroenterologie Clinique et Biologique 11, 288 -292 (1987).

98. Friedman-Kien, A. E., Saltzman, B. R., Cao, Y. et al.: Kaposi's sarcoma in HIV-negative homosexual men. Lancet 335,168-169(1990).

99. Koch, T.: Uninfected children of HIV-infected mothers may still suffer,nervous problems. CDC AIDS Weekly, p. 9, July 30(1990).

100. Achard, C., Bemard, H., Gagneux, C.: Action de la morphine sur les propri6tes leucoeytaires; leuco-diagnostic du morphinisme. Bulletin et ML&moires de la Soei(3t(e Wedicale des Höpitaux de Paris 28, 3rd Series, 958 -966 (1909).

101. Briggs, J. H., MeKerron, C. G., Souharni, R. L. et al.: Severe systemie infections complicating "mainline" heroin addiction. Lancet ii, 1227 -31 (1967).

102. Brown, S. M., Stimmel, B., Taub, R. N. et al.: Immunologic dysfunction in heroin addiets. Arch. Intern. Med. 134, 1001-06 (1974).

103. Dismukes, W. E., Karchmer, A. W., Johnson, R. F., Dougherty, W. J.: Viral hepatitis assaciated with illicit parenteral use of drugs.-J. Am. Med. Assoe. 206,1048-52 (1968).

104. Geller, S. A., Stimmel, B.: Diagnostie confusion from lymphatic lesions in heroin eddicts. Ann. Int. Med. 78, 703 -705 (19,73).

105. Harris, P. D., Garret, R.: Susceptibility of addiets to infection and neoplasia. N. Engl. J. Med. 28 7, 310 (1972).

106. Louria, D. B.: Infectious complications of nonalcoholie drug abuse. Annu. Rev. Med. 25, 219 -231 (1974).

107. MeDonough, R. J., Madden, J. J., Falek, A. et al.: Alteration of T and null lymphoeyte frequencies in the peripheral blood of human opiate addiets: in vivo evidence of opiate receptor sites on T lyrnphoeytes. J. Imraunol. 125, 2539 -43 (1980).

108. Sapira, J. D.: The narcotic addiet as a medical patient.Arn. J. Med. 45, 555 -588 (1968).

109. Terry, C. E., Pellens, M.: The Opium Problem. Bureau of Soeial Hygiene of New York (1928).

110. Cox, T. C., Jacobs, M. R., 1,eblanc, A. E., Marshman, J. A.: Drugs and Drug Abuse. (Addietion Research Foundation, Toronto, Canada) (1983).

111. Schuster, C, R.: Foreword, in: Cocaine: pharmacology, etfeets and treatment of abuse,'eds.: Grabowski, J. (NIDA Res. Monogr. 50, National Institute on Drug Abuse, Washington, DC), VII -VIII (1984).

112. Maikel, R. P.: The fate and toxicity of butyl nitrites, in: Health Hazards of Nitrite Inhalants, eds.: Haverkos, H. W., Dougherty, J. A. (NIDA Xes. Monogr. 83, National Institute on Drug Abuse, Washington, DC), 15 -27 (1988).

113. Ostürloh, J., Olson, K.: Thxicities of alkylnitrites. Ann. Intern. Med. 104, 727 (1986).

114. Hersh, E. M., Reuben, J. M., Bogerd, H. et aL: Eiteet of the reereational agent isobutyl nitrite on human peripheral blood leukoeytes and on in vitro interferon produetion. Cancer Res., 43, 1365 -71 Z1983).

115. Jorgensen, K. A., Lawesson, S.-0.: AmyInitrite and Kaposi's sarcomä in homosexual men. N. Engl. J. Med. 307, 893-894 (1982).

116. Mirvish, S. S., Ramm, M. D., Babcock, D. M.: Indieations from animal and chemical experiments of a careinogenic role for isobutyl nitrite, in: Health Hazards of Nitrite Inhalants, eds.: Haverkos, H. W., Dougherty" J. A. (NIDA Res. Monogr. 83, National Institute on Drug Abuse, Washington, DC), 39 -49 (1988).

117. Haverkos, H.W., Pinsky, P F., Drotman, D.P., Bregman, D. J.: Disease manifestation among homosexual men with acquired immunodefieieney syndrome: a possible role of nitrites in Kaposi's sarcoma. J. Sexually Transmitted Diseases 12, 203 -208 (1985).

118. Haverkos, H. W.: Nitrite inhalant abuse and AIDS-related Kaposi's sarcoma. J. Acquir. Immune Defie. Syndr. 3 supplement, S47 -S50 (1990).

119. Schnittman, S. M., Psallidopoulos, M. C., Lane, H. C. et al.: The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 245, 305 -308 (1989).

120. Simmonds, P., Balfe, P, Peutherer, J. F. ei al.: Human immunodefieieney virus-infeeted individuals contain provirus in small numbers of peripheral mononuelear cells and at low copy nurnbers. J. Virol. 64, 864 -872 (1990).

121. Benssen, L. J., Greene, J. B., Seitzman, L. E., Weinberg, H.: Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC. N. Engl. J. Med. 318, 708(1988).

122. Gorard, D. A., Guilodd, R.J.: Necrotising myopathy and zidovudine. Lanret i. 1050 (1988).

123. Cohen, S. S.: Antiretroviral therapy for AIDS. N. Engl. J. Med. 317, 629 (1987).

124. Yarchoan, R., Broder, S.: Antiretroviral therapy for AIDS. N. Engl. J. Med. 317, 630 (1987).

125. Chernov, H. 1.: Document On New Drug Application 19-655. Wood and Drug Administration, Washington, DC) (1986).

126. Elwell, L. P., Ferone, R., Freernan, G. A. et al.: Antibacterial activity and mechanism of action of 3'-azido-3'deoxythymidine (BW A5O9U). Antimierobial Agents and Chernotherapy 31, 274 -280 (1987).

127. Lauritsen, J.: Poison by Preseription -The AZT Story. (Asklepios Press, New York) (1990).

128. Freestone, D. S.: Zidovudine. Lancet 39, 626 (1992).

129. Duesberg, P H.: HIV, AIDS, and zidovudine. Lancet 339, 805-806 (1992).

130. Shenton, J.: HIV, AIDS, and zidovudine. Lancet 339, 806 (1992).

131. Duesberg, P. H.: Can alternative hypotheses survive in this era of megaprojeets? The Scientist 12, July 8, Philadelphia (1991).

132. Booth, W.: A rebel w.ithout a cause for AIDS. Science 239, 1485-88 (1988). -

133. Weiss, R., Jaffe, H.: Duesberg, HIV and AIDS. Nature (London) 345, 659 -660 (1990).

134. Levy, J.: Mysteries of HIV-. challenges for therapy and prevention. Nature (London) 333, 519 -522 (1988).

135. Selik, R. M., Buehler, J. W., Karon, J. M. et al.: Impact of the 1987 revision of the case definition of acquired immune deficieney syndrome in the United States. J. Acquir. Immune Defie. Syndr. 3, 73 -82 (1990).

136. Francis, D. R: The search for the cause, in: The AIDS Epidemic, eds.: Cahill, K. M. (St. Martin's Press, New York), 137-148 (1983).

137. Williams, A. E., Fang, C.T., Sandler, G.: HTLVJ/II and blood transfusion in the United States, in: Human Retrovirology: HTLV, eds.: Blattner, W.A. (Raven Press, New York), 349 -362 (1990).,